[go: up one dir, main page]

ATE343590T1 - Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o - Google Patents

Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o

Info

Publication number
ATE343590T1
ATE343590T1 AT98920571T AT98920571T ATE343590T1 AT E343590 T1 ATE343590 T1 AT E343590T1 AT 98920571 T AT98920571 T AT 98920571T AT 98920571 T AT98920571 T AT 98920571T AT E343590 T1 ATE343590 T1 AT E343590T1
Authority
AT
Austria
Prior art keywords
radical
seq
peptide sequence
formula
val
Prior art date
Application number
AT98920571T
Other languages
English (en)
Inventor
Denis Marie Bernard Chenebaux
Jean-Francois Hubert Delagneau
Stephane Jean Xavier Gadelle
Francois Yves Rieunier
Original Assignee
Bio Rad Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26233456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE343590(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9704356A external-priority patent/FR2761993B1/fr
Priority claimed from FR9802212A external-priority patent/FR2775287B1/fr
Application filed by Bio Rad Pasteur filed Critical Bio Rad Pasteur
Application granted granted Critical
Publication of ATE343590T1 publication Critical patent/ATE343590T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98920571T 1997-04-09 1998-04-06 Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o ATE343590T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704356A FR2761993B1 (fr) 1997-04-09 1997-04-09 Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
FR9802212A FR2775287B1 (fr) 1998-02-24 1998-02-24 Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o

Publications (1)

Publication Number Publication Date
ATE343590T1 true ATE343590T1 (de) 2006-11-15

Family

ID=26233456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920571T ATE343590T1 (de) 1997-04-09 1998-04-06 Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o

Country Status (20)

Country Link
US (2) US7053175B1 (de)
EP (1) EP0973802B1 (de)
JP (1) JP3560987B2 (de)
KR (1) KR100451312B1 (de)
CN (1) CN1215082C (de)
AT (1) ATE343590T1 (de)
AU (1) AU740231B2 (de)
BR (1) BRPI9809078B8 (de)
CA (1) CA2286344C (de)
CZ (1) CZ300927B6 (de)
DE (1) DE69836265T2 (de)
ES (1) ES2275305T3 (de)
IL (2) IL132166A0 (de)
NO (1) NO329149B1 (de)
NZ (1) NZ500015A (de)
PL (1) PL194863B1 (de)
PT (1) PT973802E (de)
RU (1) RU2184742C2 (de)
TR (1) TR199902757T2 (de)
WO (1) WO1998045323A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560987B2 (ja) * 1997-04-09 2004-09-02 ビオ―ラド・パストゥール グループｏ ｈｉｖ−１ウイルスによる感染検出用の生物学的アッセイに有用な合成ペプチド
CA2290217C (en) * 1998-11-30 2010-01-12 Ortho-Clinical Diagnostics, Inc. Peptides for the detection of hiv-1 group o
FR2874017B1 (fr) 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
CN104487846B (zh) * 2012-06-22 2016-12-28 生物辐射实验室股份有限公司 用作免疫测定的标准化对照的人因子xiii
CN112481246B (zh) * 2020-12-16 2022-03-29 熊猫乳品集团股份有限公司 一种生物活性多肽fspankkltpkky及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204259A (en) 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
ES2126620T5 (es) 1992-10-06 2010-05-21 Siemens Healthcare Diagnostics Products Gmbh Retrovirus del grupo de los vih y su utilizacion.
DE4405810A1 (de) * 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
GB9410044D0 (en) 1994-05-19 1994-07-06 Int Murex Tech Corp Assay
DE4430973A1 (de) 1994-07-25 1996-02-01 Boehringer Mannheim Gmbh Hapten-markierte Peptide
CA2652992C (fr) 1994-10-20 2014-10-07 Institut Pasteur Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
DE19505262C2 (de) 1995-02-16 1998-06-18 Behring Diagnostics Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
FR2731013B1 (fr) * 1995-02-27 1997-05-16 Inst Nat Sante Rech Med Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
AU5100696A (en) 1995-03-02 1996-09-18 Akzo Nobel N.V. Specific hiv-1 group o antigens
US5569553A (en) 1995-03-08 1996-10-29 Wilson Greatbatch Ltd. Battery design for achieving end-of-life indication during electrical discharge
DE19622088A1 (de) 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV-Antikörper als Kontrollproben
JP3560987B2 (ja) * 1997-04-09 2004-09-02 ビオ―ラド・パストゥール グループｏ ｈｉｖ−１ウイルスによる感染検出用の生物学的アッセイに有用な合成ペプチド
EP1003878A2 (de) 1997-07-18 2000-05-31 Innogenetics N.V. Antigene von hiv-1 gruppe o und deren verwendungen

Also Published As

Publication number Publication date
AU740231B2 (en) 2001-11-01
KR20010006216A (ko) 2001-01-26
NO994929D0 (no) 1999-10-08
PT973802E (pt) 2007-01-31
PL194863B1 (pl) 2007-07-31
WO1998045323A1 (fr) 1998-10-15
BR9809078B1 (pt) 2012-12-11
AU7338698A (en) 1998-10-30
BR9809078A (pt) 2000-08-01
IL132166A0 (en) 2001-03-19
KR100451312B1 (ko) 2004-10-06
BRPI9809078B8 (pt) 2021-05-25
CZ357599A3 (cs) 2000-06-14
JP3560987B2 (ja) 2004-09-02
JP2001519800A (ja) 2001-10-23
NO994929L (no) 1999-12-08
CN1256695A (zh) 2000-06-14
CZ300927B6 (cs) 2009-09-16
US20060234213A1 (en) 2006-10-19
DE69836265T2 (de) 2007-05-31
NZ500015A (en) 2001-06-29
US7838001B2 (en) 2010-11-23
PL336115A1 (en) 2000-06-05
TR199902757T2 (xx) 2000-02-21
ES2275305T3 (es) 2007-06-01
RU2184742C2 (ru) 2002-07-10
CA2286344C (fr) 2012-08-07
EP0973802B1 (de) 2006-10-25
EP0973802A1 (de) 2000-01-26
CN1215082C (zh) 2005-08-17
DE69836265D1 (de) 2006-12-07
NO329149B1 (no) 2010-08-30
IL132166A (en) 2006-12-10
US7053175B1 (en) 2006-05-30
CA2286344A1 (fr) 1998-10-15

Similar Documents

Publication Publication Date Title
Denkewalter et al. Total synthesis of an enzyme. I. Objective and strategy
Karplus et al. Amino acid sequence of spinach ferredoxin: NADP oxidoreductase
Butler Chemical studies on the cyanogen bromide peptides of rat skin collagen. Covalent structure of α1-CB5, the major hexose-containing cyanogen bromide peptide of α1
CA1246054A (en) Synthetic st toxin, process for its preparation and its use as a vaccinating agent
DE68913935D1 (de) Verfahren zur Herstellung von Retro-Inverso-Peptiden und dessen Zwischenprodukte.
Atherton et al. Peptide synthesis. Part 7. Solid-phase synthesis of conotoxin G1
Jupp et al. Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E
MX2023005771A (es) Tetrapeptido y composiciones que comprenden tetrapeptidos.
Nolan et al. Primary structure of the cytochrome c from the great grey kangaroo, Macropus canguru
ATE343590T1 (de) Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o
GB1521919A (en) Process for the manufacture of human insulin
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
ZA200109110B (en) Long lasting fusion peptide inhibitors or viral infection.
Buck et al. Comparative investigations on the amino-acid sequences of different isolectins from the sponge Axinella polypoides (Schmidt)
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
Bruton The infrastructure of valyl-transfer Ribonucleic Acid synthetase from yeast
ATE135407T1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
Gish Studies on the Amino Acid Sequence of Tobacco Mosaic Virus (TMV) Protein. IV. The Amino Acid Sequences of an Eicosapeptide and a Heptadecapeptide Isolated from a Tryptic Digest of TMV Protein1
AU623687B2 (en) New pentapeptide and a process for the preparation thereof
Morley et al. MPF analogue with high stability to proteolysis
DE68904578D1 (de) Enzym zur alpha-amidierung von c-termini und verfahren zu dessen herstellung.
DE60125386D1 (de) Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins
MX2023005770A (es) Tetrapeptido y composiciones que comprenden tetrapeptidos.
Aubert et al. Circular dichroism studies on the proline-rich glycoprotein of human parotid saliva
ES2063223T3 (es) Anticuerpos contra secuencias de aminoacidos muy conservadas de sustancias inmunogenas, procedimiento para la preparacion de estos anticuerpos, asi como su utilizacion en inmunoensayos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties